Reply: Trazodone to change the risk of neurodegeneration: bedside to bench

Mark Halliday¹, Giovanna R Mallucci^{1

2}

Affiliations

¹ MRC Toxicology Unit, Hodgkin Building, Lancaster Road, Leicester LE1 9HN, UK.
² Department of Clinical Neurosciences, University of Cambridge, Cambridge Biomedical Campus, Cambridge, CB2 0AH, UK.

Comment

Mark Halliday et al. Brain. 2017.

. 2017 Aug 1;140(8):e48.

doi: 10.1093/brain/awx150.

Mark Halliday¹, Giovanna R Mallucci^{1

2}

¹ MRC Toxicology Unit, Hodgkin Building, Lancaster Road, Leicester LE1 9HN, UK.
² Department of Clinical Neurosciences, University of Cambridge, Cambridge Biomedical Campus, Cambridge, CB2 0AH, UK.

No abstract available

Comment on

Repurposed drugs targeting eIF2α-P-mediated translational repression prevent neurodegeneration in mice.
Halliday M, Radford H, Zents KAM, Molloy C, Moreno JA, Verity NC, Smith E, Ortori CA, Barrett DA, Bushell M, Mallucci GR. Halliday M, et al. Brain. 2017 Jun 1;140(6):1768-1783. doi: 10.1093/brain/awx074. Brain. 2017. PMID: 28430857 Free PMC article.
Trazodone to change the risk of neurodegeneration: bedside to bench.
Camargos EF, Nóbrega OT. Camargos EF, et al. Brain. 2017 Aug 1;140(8):e47. doi: 10.1093/brain/awx149. Brain. 2017. PMID: 28641375 No abstract available.